Please assess the completion status of the following clinical trial:

Trial Title: Topical Budesonide Treatment for Eosinophilic Esophagitis (EoE)

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* New diagnosis of eosinophilic esophagitis (per 2007 consensus guidelines)~Exclusion Criteria:~* Age \< 18~* Inability to read or understand English~* Pregnant or nursing women~* Previous allergic reactions to steroid medications~* Current use of systemic steroids

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- inhaled/swallowed budesonide (Type: EXPERIMENTAL): None
- viscous/swallowed budesonide (Type: ACTIVE_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).